ImmunityBio, Inc. IBRX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $205.19M+238% | $88.33M-38.4% | $60.24M-46.2% | $137.66M+5.8% | $60.66M-54.4% | ||
| $175.69M+18,771% | $154.48M+2,321% | $197.57M+974% | $16M-81.8% | $931K-97.5% | ||
| $43.27M+154% | $42.57M+1,704% | $32.02M+667% | $22.13M+2,042% | $17.03M— | ||
| $18.86M+123% | $13.51M— | $6.7M+242% | $6.64M+267% | $8.44M— | ||
| $452.95M+315% | $314.88M+70.6% | $329.5M+102% | $208.13M-14.3% | $109.16M-44.2% | ||
| $112.79M-16.6% | $114.26M-16.7% | $129.6M-7.0% | $133M-6.3% | $135.27M-5.7% | ||
| $910K0.0% | $910K0.0% | $910K0.0% | $910K— | $910K— | ||
| $11.91M-15.0% | $12.99M— | $13.53M-10.1% | $13.51M-13.1% | $14.02M-12.7% | ||
| $646.64M+113% | $501.9M+31.1% | $518.99M+42.4% | $402.08M-9.5% | $303.76M-24.2% | ||
| $53K— | $52K— | $50K— | $49K+123% | —— | ||
| $67.95M+38.1% | $61.75M+12.4% | $57.13M-6.3% | $50.64M-18.5% | $49.21M-8.5% | ||
| $404.3M+36.5% | $324.62M+14.1% | $316.15M+15.5% | $307.05M+16.6% | $296.29M+81.3% | ||
| $1.52B+69.5% | $1B+15.0% | $1.04B-6.0% | $971.9M-14.9% | $894.24M-18.1% | ||
| 1.7B+22.2% | 1.7B+1,941,076% | 1.4B0.0% | 1.4B0.0% | 1.4B0.0% | ||
| -$4.36B-24.4% | -$3.73B-10.4% | -$3.66B-10.5% | -$3.6B-11.4% | -$3.5B-13.2% | ||
| -$870.01M-47.1% | -$500.47M-2.3% | -$524.32M+29.6% | -$570.75M+18.3% | -$591.43M+14.5% | ||
| $646.64M+113% | $501.9M+31.1% | $518.99M+42.4% | $402.08M-9.5% | $303.76M-24.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ImmunityBio, Inc.'s total assets?
- ImmunityBio, Inc. (IBRX) holds $646.6M in total assets, up 112.9% year over year.
- How much debt does ImmunityBio, Inc. have?
- ImmunityBio, Inc. carries $445.4M in total debt against -$870.0M of shareholders' equity, a debt-to-equity ratio of 0.11.
- How much cash does ImmunityBio, Inc. have?
- ImmunityBio, Inc. holds $205.2M in cash and equivalents.
- Can ImmunityBio, Inc. cover its short-term obligations?
- Its current ratio is 6.67 — current assets exceed current liabilities.
- Where does ImmunityBio, Inc.'s balance sheet data come from?
- Every line is extracted from ImmunityBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
